You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma, Experimental

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Brain Metastases Trial in Spain (Ipilimumab)

Completed
Has Results
  • Melanoma
  • Brain Metastases
  • Badalona, Spain
  • +11 more
Oct 10, 2022

Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitation
  • Melanoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 6, 2023

    Cancer, Cancer, Treatment-Related Trial in Chicago (ImmunOncoTool Condition)

    Completed
    • Cancer
    • Cancer, Treatment-Related
    • ImmunOncoTool Condition
    • Chicago, Illinois
      Northwestern University
    Apr 5, 2022

    AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

    Recruiting
    • AIDS-Related Non-Hodgkin Lymphoma
    • +29 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Birmingham, Alabama
    • +12 more
    Aug 4, 2022

    Melanoma Metastatic, BRAF V600 Mutation Trial in Italy (Experimental combination beyond Focal Progression, Pembrolizumab or

    Active, not recruiting
    • Melanoma Metastatic
    • BRAF V600 Mutation
    • Experimental combination beyond Focal Progression
    • Pembrolizumab or Nivolumab
    • Bari, BA, Italy
    • +13 more
    Dec 1, 2021

    Solid Tumors, Metastatic Melanoma, NSCLC Trial in Worldwide (RO7247669)

    Recruiting
    • Solid Tumors
    • +3 more
    • San Diego, California
    • +20 more
    Aug 19, 2022

    Pleural Mesothelioma Malignant Advanced, Peritoneal Mesothelioma Malignant Advanced, Non-squamous Non-small Cell Lung Carcinoma

    Terminated
    • Pleural Mesothelioma Malignant Advanced
    • +6 more
    • ADI-PEG 20
    • Rochester, Minnesota
    • +3 more
    Sep 24, 2020

    Melanoma Trial (Tranexamic acid, Saline)

    Not yet recruiting
    • Melanoma
    • (no location specified)
    Jun 2, 2023

    Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +4 more
    • Los Angeles, California
    • +34 more
    Jan 25, 2023

    Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, Pembrolizumab/Quavonlimab)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +5 more
    • Los Angeles, California
    • +39 more
    Jan 25, 2023

    Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +5 more
    • Los Angeles, California
    • +28 more
    Jan 25, 2023

    Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

    Recruiting
    • Malignant Melanoma
    • +3 more
    • SCIB1 DNA vaccine
    • Cardiff, United Kingdom
    • +6 more
    Dec 7, 2022

    Uveal Melanoma Trial in Grand Rapids (Darovasertib)

    Recruiting
    • Uveal Melanoma
    • Grand Rapids, Michigan
      The Cancer and Hematology Centers
    Jun 14, 2023

    Blocking TNF to Potentiate ICI-dependent Immune Awakening in

    Recruiting
    • Melanoma
    • +2 more
      • Toulouse, France
        Institut Claudius Regaud
      May 25, 2023

      Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)

      Not yet recruiting
      • Clinical Stage IIA Cutaneous Melanoma AJCC v8
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Nov 27, 2023

      Melanoma Trial in Scottsdale (Educational Intervention, Questionnaire Administration)

      Active, not recruiting
      • Melanoma
      • Educational Intervention
      • Questionnaire Administration
      • Scottsdale, Arizona
        Mayo Clinic in Arizona
      Jan 4, 2023

      Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

      Active, not recruiting
      • Tumor Skin
      • +2 more
      • OBX-115
      • Orlando, Florida
      • +1 more
      Sep 28, 2023

      Melanoma Trial in Beijing (IBI363)

      Not yet recruiting
      • Melanoma
      • IBI363
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Oct 7, 2023

      Melanoma, Melanoma Stage III Trial in New York (diagnostic test, drug, procedure)

      Recruiting
      • Melanoma
      • Melanoma Stage III
      • PET Scan
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Jun 24, 2022

      Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

      Not yet recruiting
      • Melanoma
      • Fluzoparib Camrelizumab Temozolomide
      • (no location specified)
      Aug 9, 2023

      Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal

      Recruiting
      • Choroidal Melanoma
      • +3 more
      • Belzupacap Sarotalocan
      • +5 more
      • Birmingham, Alabama
      • +32 more
      Aug 23, 2023

      Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

      Not yet recruiting
      • Melanoma Stage III
      • Toripalimab combined with Temozolomide
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Apr 23, 2023

      Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Nov 22, 2023

      Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

      Enrolling by invitation
      • Malignant Melanomas
      • Recombinant Human Adenovirus Type 5 Injection
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
      Jul 7, 2023

      Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

      Not yet recruiting
      • Uveal Melanoma
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Oct 5, 2023